Nadia Dac

Corporate Officer/Principal at OMEROS CORPORATION

54 year

Health Technology

Consumer Services

Profile

Nadia Dac currently works at Omeros Corp., as Chief Commercial Officer from 2021.
Ms. Dac also formerly worked at Auxilium Pharmaceuticals LLC, as Vice President-Marketing from 2013 to 2014, AbbVie, Inc., as VP-Global Specialty Commercial Development from 2014 to 2019, Novartis AG, as VP-Neuroscience Professional Relations from 2009 to 2013, and Lundbeck Seattle BioPharmaceuticals, Inc., as Chief Commercial Officer from 2019 to 2020.
Ms. Dac received her undergraduate degree from Rutgers State University of New Jersey.

Nadia Dac active positions

Companies	Position	Start
OMEROS CORPORATION	Corporate Officer/Principal	2021-01-25

All active positions of Nadia Dac

Former positions of Nadia Dac

Companies	Position	End
ALDER BIOPHARMACEUTICALS, INC.	Corporate Officer/Principal	2020-05-31
ABBVIE INC.	Corporate Officer/Principal	2019-02-28
AUXILIUM PHARMACEUTICALS, INC.	Sales & Marketing	2014-08-31
NOVARTIS AG	Corporate Officer/Principal	2012-12-31

See the detail of Nadia Dac's experience

Training of Nadia Dac

Rutgers State University of New Jersey

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nadia Dac's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
OMEROS CORPORATION	Health Technology
ABBVIE INC.	Health Technology
NOVARTIS AG	Health Technology

Private companies	2
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.	Health Technology
Auxilium Pharmaceuticals LLC Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA.	Health Technology